Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 191,500 shares, a growth of 441.0% from the April 30th total of 35,400 shares. Based on an average daily trading volume, of 185,700 shares, the days-to-cover […]
Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) had its target price cut by HC Wainwright from $25.00 to $13.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.31) EPS. A number of other research firms […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) saw a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 36,300 shares, a decrease of 85.1% from the June 15th total of 244,200 shares. Based on an average daily trading volume, of 198,000 shares, the days-to-cover […]
Cantor Fitzgerald reissued their overweight rating on shares of Eledon Pharmaceuticals (NASDAQ:ELDN – Get Rating) in a report published on Monday morning, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.83) EPS. Eledon Pharmaceuticals Stock Down 0.4 % Shares of NASDAQ:ELDN opened at $2.24 on Monday. The stock has a […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 28,700 shares, an increase of 64.9% from the March 15th total of 17,400 shares. Based on an average daily trading volume, of 25,700 shares, […]